Free Trial
NASDAQ:MTSR

Metsera (MTSR) Stock Price, News & Analysis

Metsera logo
$40.59 +0.93 (+2.34%)
As of 01:15 PM Eastern

About Metsera Stock (NASDAQ:MTSR)

Key Stats

Today's Range
$37.29
$40.59
50-Day Range
$25.38
$44.30
52-Week Range
$12.30
$47.40
Volume
481,368 shs
Average Volume
898,198 shs
Market Capitalization
$4.26 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$55.00
Consensus Rating
Buy

Company Overview

Receive MTSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Metsera and its competitors with MarketBeat's FREE daily newsletter.

MTSR Stock News Headlines

Metsera Inc.'s (NASDAQ:MTSR) Lock-Up Period To Expire on July 30th
Metsera (NASDAQ:MTSR) Reaches New 52-Week High - Should You Buy?
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
See More Headlines

MTSR Stock Analysis - Frequently Asked Questions

Metsera's stock was trading at $29.50 at the start of the year. Since then, MTSR stock has increased by 28.4% and is now trading at $37.89.

Metsera Inc. (NASDAQ:MTSR) issued its quarterly earnings results on Monday, May, 12th. The company reported ($1.03) EPS for the quarter.

Metsera (MTSR) raised $275 million in an initial public offering (IPO) on Friday, January 31st 2025. The company issued 15,277,778 shares at $18.00 per share.

Metsera's lock-up period expires on Wednesday, July 30th. Metsera had issued 15,277,778 shares in its initial public offering on January 31st. The total size of the offering was $275,000,004 based on an initial share price of $18.00. After the end of the company's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Metsera's top institutional investors include Exchange Traded Concepts LLC (0.04%) and KLP Kapitalforvaltning AS.

Shares of MTSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/12/2025
Today
7/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MTSR
Previous Symbol
NASDAQ:MTSR
CIK
2040807
Web
N/A
Fax
N/A
Employees
81
Year Founded
N/A

Price Target and Rating

High Price Target
$65.00
Low Price Target
$38.00
Potential Upside/Downside
+38.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.55
Quick Ratio
6.55

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.46) per share
Price / Book
-16.12

Miscellaneous

Outstanding Shares
105,060,000
Free Float
N/A
Market Cap
$4.17 billion
Optionable
N/A
Beta
N/A

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:MTSR) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners